156 related articles for article (PubMed ID: 24384015)
1. RAS in FGF23: another piece in the puzzle.
Ovejero D; Collins MT
J Clin Endocrinol Metab; 2014 Jan; 99(1):63-6. PubMed ID: 24384015
[No Abstract] [Full Text] [Related]
2. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23.
Avitan-Hersh E; Tatur S; Indelman M; Gepstein V; Shreter R; Hershkovitz D; Brick R; Bergman R; Tiosano D
J Clin Endocrinol Metab; 2014 Jan; 99(1):E132-6. PubMed ID: 24243633
[TBL] [Abstract][Full Text] [Related]
3. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.
Lim YH; Ovejero D; Derrick KM; ; Collins MT; Choate KA
J Am Acad Dermatol; 2016 Aug; 75(2):420-7. PubMed ID: 27444071
[TBL] [Abstract][Full Text] [Related]
5. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.
Hafner C; Toll A; Real FX
N Engl J Med; 2011 Nov; 365(20):1940-2. PubMed ID: 22087699
[No Abstract] [Full Text] [Related]
6. [Neurocutaneous melanosis and multiple congenital melanocytic naevi are associated with post-zygotic N-ras mutations].
Dereure O
Ann Dermatol Venereol; 2014 Apr; 141(4):314-5. PubMed ID: 24703650
[No Abstract] [Full Text] [Related]
7. Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome.
Carli D; Cardaropoli S; Tessaris D; Coppo P; La Selva R; Cesario C; Lepri FR; Pullano V; Palumbo M; Ramenghi U; Brusco A; Medico E; De Sanctis L; Ferrero GB; Mussa A
Genes Chromosomes Cancer; 2022 Dec; 61(12):740-746. PubMed ID: 35999193
[TBL] [Abstract][Full Text] [Related]
8. N-Ras mutation in vemurafenib-associated expanding melanocytic nevus.
Harada K; Kato Y; Maeda T; Yoshida M; Irisawa R; Nagao T; Tsuboi R
J Dermatol; 2017 May; 44(5):e101-e102. PubMed ID: 27790745
[No Abstract] [Full Text] [Related]
9. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.
Ovejero D; Lim YH; Boyce AM; Gafni RI; McCarthy E; Nguyen TA; Eichenfield LF; DeKlotz CM; Guthrie LC; Tosi LL; Thornton PS; Choate KA; Collins MT
Osteoporos Int; 2016 Dec; 27(12):3615-3626. PubMed ID: 27497815
[TBL] [Abstract][Full Text] [Related]
10. Inheritance of giant pigmented hairy nevus of the scalp.
Hecht F; LaCanne KM; Carroll DB
Am J Med Genet; 1981; 9(2):177-8. PubMed ID: 7258230
[No Abstract] [Full Text] [Related]
11. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome.
Hoffman WH; Jueppner HW; Deyoung BR; O'dorisio MS; Given KS
Am J Med Genet A; 2005 Apr; 134(3):233-6. PubMed ID: 15742370
[TBL] [Abstract][Full Text] [Related]
12. Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.
Martin RJ; Arefi M; Splitt M; Redford L; Moss C; Rajan N
Br J Dermatol; 2018 Jan; 178(1):289-291. PubMed ID: 28489335
[No Abstract] [Full Text] [Related]
13. [Nevus-cell nevus, melanosis extensiva Hutchinson, Schwann-cell nevus (syn. juvenile melanoma). I. Nevus-cell nevi and the control of their development].
Schreus HT
Hautarzt; 1969 Nov; 20(11):490-1. PubMed ID: 4915766
[No Abstract] [Full Text] [Related]
14. Identification of somatic KRAS mutation in a Korean baby with nevus sebaceus syndrome.
Kim SW; Song JS; Kang MS; Sin JB; Ki CS; Jeon GW
Ann Lab Med; 2015 Jan; 35(1):178-80. PubMed ID: 25553307
[No Abstract] [Full Text] [Related]
15. The role of oncogenes and growth factors in progressive melanoma-genesis.
Albino AP
Pigment Cell Res; 1992; Suppl 2():199-218. PubMed ID: 1409423
[No Abstract] [Full Text] [Related]
16. HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.
Jennings L; Cummins R; Murphy GM; Gulmann C; O'Kane M
Clin Exp Dermatol; 2017 Oct; 42(7):791-792. PubMed ID: 28736904
[No Abstract] [Full Text] [Related]
17. Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus.
Porubsky C; Teer JK; Zhang Y; Deschaine M; Sondak VK; Messina JL
J Cutan Pathol; 2018 Feb; 45(2):180-183. PubMed ID: 29210482
[TBL] [Abstract][Full Text] [Related]
18. Hypophosphatemic rickets: A rare complication of congenital melanocytic nevus syndrome.
Welfringer-Morin A; Pinto G; Baujat G; Vial Y; Hadj-Rabia S; Bodemer C; Boccara O
Pediatr Dermatol; 2020 May; 37(3):541-544. PubMed ID: 32157705
[TBL] [Abstract][Full Text] [Related]
19. Familial nevus fusco-caeruleus zygomaticus.
Yang B; Li L; Hu N; Li Y; Deng C
Int J Dermatol; 2011 Jul; 50(7):858-9. PubMed ID: 21470213
[No Abstract] [Full Text] [Related]
20. Phacomatosis pigmentokeratotica is a "pseudodidymosis".
Happle R
J Invest Dermatol; 2013 Aug; 133(8):1923-5. PubMed ID: 23856930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
